85248-107update

Manufacturer
Jiangxi Yudexi Pharmaceutical Co., LTD
Effective date
2026-07-21
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-07-25 05:10:13

Label at a glance#

ProductSERYNTH MILIA REMOVER
Active ingredientSALICYLIC ACID
Label structure12 sections

Dosage and administration

1.Cleanse and dry the affected skin area thoroughly.2.Apply a thin layer of the product directly onto the milia (skin bumps) once or twice daily, as needed.3.Gently massage until fully absorbed.4.For best results, use consistently for 4 weeks.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 1%

Purpose

OTC - PURPOSE SECTION

Milia Remover

Use

INDICATIONS & USAGE SECTION

For the removal of milia (skin bumps)Aids in exfoliating dead skin cells Helps smooth skin texture

Warnings

WARNINGS SECTION

For external use only,

Do not use

OTC - DO NOT USE SECTION

condition worsens or does not improve within 4 weeks,Severe redness, burning, or swelling occurs.
If pregnant or breast-feeding, ask a health professional before use.

When Using

OTC - STOP USE SECTION

Avoid contact with eyes.lips.and mucous membranes. If contact occurs,rinse thoroughly with water. Do not apply to broken,irritated,or sunburned skin.Excessive drying or peeling may occur.If severe irritation develops,discontinue use.

Stop Use

OTC - STOP USE SECTION

condition worsens or does not improve within 4 weeks,Severe redness, burning, or swelling occurs.
If pregnant or breast-feeding, ask a health professional before use.

Ask Doctor

OTC - ASK DOCTOR SECTION

condition worsens or does not improve within 4 weeks,Severe redness, burning, or swelling occurs.
If pregnant or breast-feeding, ask a health professional before use.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

1.Cleanse and dry the affected skin area thoroughly.2.Apply a thin layer of the product directly onto the milia (skin bumps) once or twice daily, as needed.3.Gently massage until fully absorbed.4.For best results, use consistently for 4 weeks.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Glycerin, dextrin,xanthan gum,amylopectin, tocopheryl acetate.water.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-136979843980760GTIN-13: 6979843980760
EAN-13: 6979843980760
GTIN storage (14 digits): 06979843980760
SERYNTH MILIA REMOVER ESSENCE.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85248-10785248-107-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-02-08full-release2026-06-01 01:37:32

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SERYNTH MILIA REMOVERSALICYLIC ACID 1% MILIA REMOVERJiangxi Yudexi Pharmaceutical Co., LTD4a4c3bfa-32ec-c0dd-e063-6394a90ab15c2026-07-21WarningsExact identifier
ndc (package): 85248-107-01
ndc (product): 85248-107
ndc11 (package): 85248010701
spl id: 572b3a3c-d635-1d46-e063-6394a90ad56c
spl set id: 4a4c3bfa-32ec-c0dd-e063-6394a90ab15c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.